AA
RVNC
AlphaCentric Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-245,000
| Closed | -$1.27M | – | 292 |
|
|
2024
Q3 | $1.27M | Hold |
245,000
| – | – | 0.95% | 34 |
|
|
2024
Q2 | $630K | Hold |
245,000
| – | – | 0.46% | 69 |
|
|
2024
Q1 | $1.21M | Buy |
245,000
+25,000
| +11% | +$123K | 0.73% | 55 |
|
|
2023
Q4 | $1.93M | Buy |
220,000
+30,000
| +16% | +$264K | 1.3% | 24 |
|
|
2023
Q3 | $2.18M | Buy |
+190,000
| New | +$2.18M | 1.24% | 21 |
|
|
2021
Q4 | $1.06M | Buy |
65,000
+58,500
| +900% | +$955K | 0.31% | 30 |
|
|
2021
Q3 | $181K | Hold |
6,500
| – | – | 0.05% | 114 |
|
|
2021
Q2 | $193K | Hold |
6,500
| – | – | 0.05% | 107 |
|
|
2021
Q1 | $182K | Buy |
6,500
+4,000
| +160% | +$112K | 0.06% | 98 |
|
|
2020
Q4 | $71K | Buy |
+2,500
| New | +$71K | 0.03% | 163 |
|